Author

M. Hergueta-Redondo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

H. Peinado· 3 shared J. Munoz· 2 shared A. Amor Lopez· 1 shared A. Benito-Martin· 1 shared A. Capuano· 1 shared A. Carretero-Gonzalez· 1 shared D. Castellano· 1 shared D. Megias· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

H. Peinado

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion.

A. Benito-Martin, M. Hergueta-Redondo, L. Nogues, E. Castellano-Sanz, E. Garvin, M. Cioffi, P. Sola-Castrillo, W. Buehring, M. P. Ximenez-Embun, J. Munoz, I. Matei, J. Villanueva, H. Peinado

This study shows mast cells inhibit melanoma metastasis by reducing HMGA1 secretion, with HMGA1 expression linked to poorer survival in human melanoma.

bioRxiv · May 31, 2022Cancer Biology

Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis.

A. Carretero-Gonzalez, S. Sanchez-Redondo, L. M. Sanchez, E. C. Gil, D. Castellano, M. Hergueta-Redondo, G. de Velasco, H. Peinado

This study characterizes plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastases, finding reduced EV numbers and increased PD-L1 in melanoma patients with brain metastases.

bioRxiv · Nov 18, 2021Cancer Biology

Inactivation of EMILIN-1 by proteolysis and secretion in small extracellular vesicles favors melanoma progression and metastasis.

A. Amor Lopez, M. S. Mazariegos, A. Capuano, P. Ximenez Embun, M. Hergueta-Redondo, J. Angel Recio, E. Munoz, F. Al Shahrour, J. Munoz, D. Megias, R. Doliana, P. Spessotto, H. Peinado

The paper shows that EMILIN-1 is proteolyzed and secreted in small EVs, reducing its tumor suppressive effects and promoting melanoma progression and metastasis.

bioRxiv · Jun 2, 2021 · PreprintCancer Biology